To access the full text documents, please follow this link: http://hdl.handle.net/2445/118953
dc.contributor.author | Santín Cerezales, Miguel |
---|---|
dc.contributor.author | Shaw Perujo, Evelyn |
dc.contributor.author | Garcia, Maria Jose |
dc.contributor.author | Delejido, Antonio |
dc.contributor.author | Rodriguez De Castro, Eduardo |
dc.contributor.author | Rota, Rosa |
dc.contributor.author | Altés, Jordi |
dc.contributor.author | Baguena, Francisco |
dc.contributor.author | Valero, Silvia |
dc.contributor.author | Sala, Montserrat |
dc.contributor.author | Casanova Rituerto, Aurora |
dc.contributor.author | HCV/HIV-01 Study Team |
dc.date | 2018-01-10T11:29:09Z |
dc.date | 2018-01-10T11:29:09Z |
dc.date | 2006-04-19 |
dc.date | 2018-01-10T11:29:09Z |
dc.identifier.citation | 0889-2229 |
dc.identifier.citation | 544486 |
dc.identifier.uri | http://hdl.handle.net/2445/118953 |
dc.format | 6 p. |
dc.format | application/pdf |
dc.language.iso | eng |
dc.publisher | Mary Ann Liebert |
dc.relation | Reproducció del document publicat a: http://online.liebertpub.com/doi/abs/10.1089/aid.2006.22.315 |
dc.relation | Aids Research and Human Retroviruses, 2006, vol. 22, num. 4, p. 315-320 |
dc.rights | (c) Mary Ann Liebert, 2006 |
dc.rights | info:eu-repo/semantics/openAccess |
dc.subject | Interferó |
dc.subject | Efecte dels medicaments sobre els microorganismes |
dc.subject | Medicaments antivírics |
dc.subject | Infeccions per VIH |
dc.subject | Hepatitis C |
dc.subject | Interferon |
dc.subject | Effect of drugs on microorganisms |
dc.subject | Antiviral agents |
dc.subject | HIV infections |
dc.subject | Hepatitis C |
dc.title | Efficacy and safety of Pegylated Interferon-α2b Plus Ribavirin for the treatment of chronic hepatitis C in HIV-infected patients |
dc.type | info:eu-repo/semantics/article |
dc.type | info:eu-repo/semantics/publishedVersion |
dc.description.abstract |